ENGINEERED POLYPEPTIDE CONJUGATES USING TRANSGLUTAMINASE

The present invention provides engineered polypeptide conjugates (e.g., antibody-drug-conjugates) comprising specific acyl donor glutamine-containing tags and amine donor agents. The invention also provides methods of making such engineered polypeptide conjugates using transglutaminase and methods o...

Full description

Saved in:
Bibliographic Details
Main Authors Farias, Santiago Esteban, Galindo Casas, Meritxell, Strop, Pavel
Format Patent
LanguageEnglish
Published 24.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides engineered polypeptide conjugates (e.g., antibody-drug-conjugates) comprising specific acyl donor glutamine-containing tags and amine donor agents. The invention also provides methods of making such engineered polypeptide conjugates using transglutaminase and methods of using thereof.
Bibliography:Application Number: US201816231242